EFFICACY AND SAFETY OF IBANDRONIC ACID ADMINISTERED INTRAVENOUSLY TO JUVENILE ARTHRITIS PATIENTS WITH SEVERE SYSTEM OSTEOPOROSIS

EFFICACY AND SAFETY OF IBANDRONIC ACID ADMINISTERED INTRAVENOUSLY TO JUVENILE ARTHRITIS PATIENTS WITH SEVERE SYSTEM OSTEOPOROSIS

Show other versions (1)

The article is dedicated to study of efficacy and safety of ibandronic acid administered intravenously to 25 patients suffering from juvenile arthritis and system osteoporosis. It was concluded that administration of 3 mg of ibandronate every 3 months during 76 weeks increase  CTX, which indicates i...

Full description

Bibliographic Details
Main Authors: R.V. Denisova, E.I. Alexeeva, V.G. Pinelis, M.I. Bakanov, S.I. Valieva, T.M. Bzarova, K.B. Isaeva, S.Yu. Morev, G.V. Kuznetsova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2011-11-01
Series:Voprosy Sovremennoj Pediatrii
Subjects:
child
juvenile arthritis
osteoporosis
treatment
biophosphates
ibandronic acid
Online Access:https://vsp.spr-journal.ru/jour/article/view/780

Internet

https://vsp.spr-journal.ru/jour/article/view/780

Similar Items